A prediction model for successful increase of adalimumab dose intervals: analysis of the pragmatic open-label randomised controlled non-inferiority LADI trial

被引:0
|
作者
Van Linschoten, R. [1 ,2 ]
Jansen, F. [3 ]
Pauwels, R. [2 ]
Smits, L. [3 ]
Atsma, F. [4 ]
Kievit, W. [5 ]
de Jong, D. [3 ]
de Vries, A. [2 ]
Boekema, P. [6 ]
West, R.
Bodelier, A. [7 ]
Gisbertz, I. [8 ]
Wolfhagen, F. [9 ]
Romkens, T. [10 ]
Lutgens, M. [11 ]
van Bodegraven, A. [12 ]
Oldenburg, B. [13 ]
Pierik, M. [14 ]
Russel, M. [15 ]
de Boer, N. [16 ]
Mallant-Hent, R. [17 ]
ter Borg, P. [18 ]
van der Meulen-de Jong, A. [19 ]
Jansen, J. [20 ]
Jansen, S. [21 ]
Tan, A. [22 ]
van der Woude, C. J. [2 ]
Hoentjen, F. [23 ]
机构
[1] Franciscus Gasthuis Vlietland, Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, IQ Healthcare, Nijmegen, Netherlands
[5] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Hlth Evidence, Nijmegen, Netherlands
[6] Maxima Med Ctr, Dept Gastroenterol & Hepatol, Eindhoven, Netherlands
[7] Amphia Hosp, Dept Gastroenterol & Hepatol, Breda, Netherlands
[8] Bernhoven Hosp, Dept Gastroenterol & Hepatol, Uden, Netherlands
[9] Albert Schweitzer Hosp, Dept Gastroenterol & Hepatol, Dordrecht, Netherlands
[10] Jeroen Bosch Hosp, Dept Gastroenterol & Hepatol, Shertogenbosch, Netherlands
[11] Elisabeth Tweesteden Hosp, Dept Gastroenterol & Hepatol, Tilburg, Netherlands
[12] Zuyderland Med Ctr, Dept Gastroenterol Geriatr Internal & Intens Care, Heerlen, Netherlands
[13] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
[14] Maastricht Univ, Med Cter, Dept Gastroenterol & Hepatol, Maastricht, Netherlands
[15] Medisch Spectrum Twente, Dept Gastroenterol & Hepatol, Twente, Netherlands
[16] Vrije Univ Amsterdam, Amsterdam Univ, Med Ctr, Dept Gastroenterol & Hepatol,AGEM Res Inst, Amsterdam, Netherlands
[17] Flevoziekenhuis, Dept Gastroenterol & Hepatol, Almere, Netherlands
[18] Ikazia Hosp, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[19] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands
[20] OLVG, Dept Gastroenterol & Hepatol, Roterdam, Netherlands
[21] Reinier Graaf Gasthuis, Dept Gastroenterol & Hepatol, Delft, Netherlands
[22] Canisius Wilhelmina Hosp, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands
[23] Univ Alberta, Div Gastroenterol Dept Med, Edmonton, AB, Canada
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P526
引用
收藏
页码:655 / 658
页数:3
相关论文
共 50 条
  • [21] Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia
    Bashorun, Adedapo O.
    Hydara, Mariama Badjie
    Adigweme, Ikechukwu
    Umesi, Ama
    Danso, Baba
    Johnson, Njilan
    Sambou, Ngally Aboubacarr
    Fofana, Sidat
    Kanu, Francis J.
    Jeyaseelan, Visalakshi
    Verma, Harish
    Weldon, William C.
    Oberste, M. Steven
    Sutter, Roland W.
    Jeffries, David
    Wathuo, Miriam
    Mach, Ondrej
    Clarke, Ed
    LANCET GLOBAL HEALTH, 2022, 10 (02): : E257 - E268
  • [22] Early versus differed arterial catheterisation in critically ill patients with acute circulatory failure: a multicentre, open-label, pragmatic, randomised, non-inferiority controlled trial: the EVERDAC protocol
    Muller, Gregoire
    Kamel, Toufik
    Contou, Damien
    Ehrmann, Stephan
    Martin, Maelle
    Quenot, Jean-Pierre
    Lacherade, Jean-Claude
    Boissier, Florence
    Monnier, Alexandra
    Vimeux, Sylvie
    Houdard, Solene Brunet
    Tavernier, Elsa
    Boulain, Thierry
    BMJ OPEN, 2021, 11 (09):
  • [23] Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
    Cochereau, D.
    Lecuru, F.
    ONCOLOGIE, 2015, 17 (11-12) : 595 - 596
  • [24] Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial
    Bernard, Louis
    Dinh, Aurelien
    Ghout, Idir
    Simo, David
    Zeller, Valerie
    Issartel, Bertrand
    Le Moing, Vincent
    Belmatoug, Nadia
    Lesprit, Philippe
    Bru, Jean-Pierre
    Therby, Audrey
    Bouhour, Damien
    Denes, Eric
    Debard, Alexa
    Chirouze, Catherine
    Fevre, Karine
    Dupon, Michel
    Aegerter, Philippe
    Mulleman, Denis
    LANCET, 2015, 385 (9971): : 875 - 882
  • [25] Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
    Kehoe, Sean
    Hook, Jane
    Nankivell, Matthew
    Jayson, Gordon C.
    Kitchener, Henry
    Lopes, Tito
    Luesley, David
    Perren, Timothy
    Bannoo, Selina
    Mascarenhas, Monica
    Dobbs, Stephen
    Essapen, Sharadah
    Twigg, Jeremy
    Herod, Jonathan
    McCluggage, Glenn
    Parmar, Mahesh
    Swart, Ann-Marie
    LANCET, 2015, 386 (9990): : 249 - 257
  • [26] Outpatient elective induction of labour at 39 weeks' gestation (HOME INDUCTION): an open-label, randomised, controlled, phase III, non-inferiority trial
    Nicholson, Sarah M.
    Flood, Karen
    Dicker, Patrick
    Molphy, Zara E.
    Smith, Orla T.
    Oprescu, Corina I.
    Wall, Eimear M.
    Nimr, Sara N. El
    Shanahan, Ita M.
    Kennedy, Bernard J.
    V. Daly, Ronan
    Gannon, Geraldine
    Looi, Claudia
    Fernandez, Elena
    Malone, Fergal D.
    ECLINICALMEDICINE, 2024, 74
  • [27] Telemedical support for prehospital emergency medical service in severe emergencies: an open-label randomised non-inferiority clinical trial
    Ana Kowark
    Marc Felzen
    Sebastian Ziemann
    Stephanie Wied
    Michael Czaplik
    Stefan K. Beckers
    Jörg C. Brokmann
    Ralf-Dieter Hilgers
    Rolf Rossaint
    Critical Care, 27
  • [28] Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
    Sundar, Shyam
    Sinha, Prabhat Kumar
    Rai, Madhukar
    Verma, Deepak Kumar
    Nawin, Kumar
    Alam, Shanawwaj
    Chakravarty, Jaya
    Vaillant, Michel
    Verma, Neena
    Pandey, Krishna
    Kumari, Poonam
    Lal, Chandra Shekhar
    Arora, Rakesh
    Sharma, Bhawna
    Ellis, Sally
    Strub-Wourgaft, Nathalie
    Balasegaram, Manica
    Olliaro, Piero
    Das, Pradeep
    Modabber, Farrokh
    LANCET, 2011, 377 (9764): : 477 - 486
  • [29] If only they knew! A non-inferiority randomized controlled trial comparing deceptive and open-label placebo in healthy individuals
    Druart, L.
    Graham Longsworth, S. E.
    Terrisse, H.
    Locher, C.
    Blease, C.
    Rolland, C.
    Pinsault, N.
    EUROPEAN JOURNAL OF PAIN, 2024, 28 (03) : 491 - 501
  • [30] Efficacy of Bimin decoction for patients with perennial allergic rhinitis: an open-label non-inferiority randomized controlled trial
    Jingyi Zhao
    Xinyu Yan
    Jianqing Gai
    Jinshuai Han
    Hong Zhang
    Hui Luo
    Shaoting Huang
    Junge Wang
    Trials, 20